Screening

Duration of PARP Inhibitor Maintenance Therapy in Patients With Ovarian Cancer With Germline or Somatic BRCA Mutations

Joanna Billings, PharmD; Lindsay Kohler, PharmD; Jordan Wallace, PharmD; Lindsey Buckingham, MD; Amber Cipriani, PharmD, BCOP, CPP; Alexis Jones, PharmD, BCOP, CPP

Clinical, Laboratory, and Genetic Profiles and Outcomes of Patients With aHUS and Restrictive Use of Eculizumab: A Single-Center Experience

Fnu Amisha, MD; Manojna Konda, MD; Paras Malik, MD; Brad Fugere, BGS; Arya Mariam Roy, MD; Appalanaidu Sasapu, MD

Duration of Response to PARP Inhibitors for Maintenance Treatment of Ovarian Cancer in Patients With Germline or Somatic HRD

Jordanne Adolphsen, PharmD, BCOP; Taylor Monson, PharmD, BCOP; Grace Martin, PharmD, BCOP; Zahra Mahmoudjafari, PharmD, BCOP; Richard Meier, PhD; Whitney Shae, BS, MS; Devin C. Koestler, PhD; Colleen Bohnenkamp, PharmD, BCOP

Dosing of 3 Targeted Agents in Novel Drug Combinations Used at the Precision Medicine Clinic of the University of California San Diego

Mina Nikanjam, MD, PhD; Jose Tinajero, PharmD; Mary McGann, PharmD, BCOP; Jerry Li, PharmD; Jincheng Yang, PharmD; Felicity Shen, PharmD; Jason K. Sicklick, MD; Shumei Kato, MD; Edmund Capparelli, PharmD; Razelle Kurzrock, MD

Outcomes and Adverse Events Linked to Off-Label Treatment of Solid Tumors with PARP Inhibitors

Bestis Wasef, PharmD, BCOP; Kelly Fritz, PharmD, BCOP; Courtney C. Cavalieri, PharmD, BCOP

The Presence of De Novo EGFR T790M Mutation in a Tyrosine Kinase Inhibitor–Naïve Patient with Lung Adenocarcinoma: Case Report and Review of the Literature

Jessica Katiaj, PharmD; Rosemary Boshar, PharmD; Maryann R. Cooper, PharmD, BCOP; Gerald Gehr, MD

Meeting Highlights Online Only

Genetic Score Makes PSA Screening More Accurate

Meeting Highlights

NCCN Guidelines Update: Initial Colorectal Screening Lowered to Age 45

Keytruda Monotherapy FDA Approved for Endometrial Carcinoma with a Biomarker

Biomarker-Driven Targeted Therapies in Solid Tumor Malignancies

Hanjie Mo, PharmD, BCOP; Catherine Renna, PharmD, BCOP